Loading company…
Pharmacin develops modified drugs for oncology, endocrine, psychiatric, and immunology conditions.
Founded in 2016 and based in Shenzhen, Pharmacin researches and produces modified drugs, with additional offices in the United States. Its clinical-stage candidates include HLK-1001 for oncology and HLK-6002 and HLK-6006 for immunology. The company uses drug solubilization, controlled-release, freeze-drying, and topical formulation technologies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in